Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in RPRX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 43.6M | $2.09B | -21.2% | 10.170% | 0.13% |
| 2 | Capital International Investors | 35.0M | $1.68B | +12.5% | 8.171% | 0.39% |
| 3 | BlackRock, Inc. | 25.9M | $1.24B | -1.1% | 6.047% | 0.02% |
| 4 | FMR LLC | 25.2M | $1.21B | -4.3% | 5.871% | 0.06% |
| 5 | BAILLIE GIFFORD & CO | 16.2M | $775.0M | -5.0% | 3.771% | 0.79% |
| 6 | Swedbank AB | 11.6M | $555.8M | -3.0% | 2.704% | 0.58% |
| 7 | STATE STREET CORP | 11.0M | $527.2M | +3.2% | 2.565% | 0.02% |
| 8 | Capital World Investors | 8.0M | $385.5M | — | 1.876% | 0.05% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 7.9M | $376.5M | +1.9% | 1.837% | 0.02% |
| 10 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 7.5M | $358.8M | -36.3% | 1.746% | 0.55% |
| 11 | Caledonia (Private) Investments Pty Ltd | 7.2M | $343.9M | -2.8% | 1.673% | 10.00% |
| 12 | VANGUARD CAPITAL MANAGEMENT LLC | 4.5M | $217.4M | — | 1.058% | 0.01% |
| 13 | VICTORY CAPITAL MANAGEMENT INC | 3.9M | $184.9M | -24.5% | 0.899% | 0.12% |
| 14 | NORTHERN TRUST CORP | 3.8M | $182.7M | -4.9% | 0.889% | 0.02% |
| 15 | ROYAL LONDON ASSET MANAGEMENT LTD | 3.8M | $182.7M | +2019.5% | 0.889% | 0.38% |
| 16 | Invesco Ltd. | 3.8M | $180.0M | +149.8% | 0.876% | 0.03% |
| 17 | AQR CAPITAL MANAGEMENT LLC | 3.8M | $179.6M | +47.5% | 0.883% | 0.08% |
| 18 | Patient Capital Management, LLC | 3.6M | $174.8M | +9.3% | 0.851% | 6.52% |
| 19 | BANK OF AMERICA CORP /DE/ | 3.5M | $167.7M | +29.0% | 0.816% | 0.01% |
| 20 | Legal & General Group Plc | 3.4M | $161.3M | +8.9% | 0.785% | 0.04% |
| 21 | UBS ASSET MANAGEMENT AMERICAS INC | 3.1M | $148.5M | -0.7% | 0.723% | 0.03% |
| 22 | Amundi | 3.1M | $148.2M | +15.3% | 0.721% | 0.04% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.0M | $145.2M | +3.9% | 0.707% | 0.02% |
| 24 | CITADEL ADVISORS LLC | 2.9M | $141.0M | -45.2% | 0.686% | 0.07% |
| 25 | NEW SOUTH CAPITAL MANAGEMENT INC | 2.6M | $126.0M | -10.3% | 0.613% | 6.04% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in RPRX — a direct measure of their conviction.
Filings activity in RPRX during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 574 | +8.1% | 69.98% | +12.50 pp | $16.45B | +22% |
| Q4 2025 | 531 | +11% | 57.48% | +9.34 pp | $13.51B | +19% |
| Q3 2025 | 477 | +5.3% | 48.14% | 3.49 pp | $11.32B | 6.8% |
| Q2 2025 | 453 | +4.6% | 51.63% | +10.72 pp | $12.14B | +26% |
| Q1 2025 | 433 | +7.2% | 40.91% | +7.45 pp | $9.62B | +22% |
| Q4 2024 | 404 | +5.5% | 33.46% | 3.02 pp | $7.86B | 8.3% |
| Q3 2024 | 383 | +2.1% | 36.48% | 2.24 pp | $8.58B | 5.8% |
| Q2 2024 | 375 | — | 38.72% | — | $9.10B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying RPRX stock.
Based on Q1 2026 13F filings, institutional ownership of Royalty Pharma plc stands at 70.0%, held across 574 reporting institutions.
MORGAN STANLEY is the largest reported institutional holder of RPRX, with approximately 43,571,633 shares worth $2.09B as of Q1 2026.
Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of RPRX, including CITADEL ADVISORS LLC.
Our composite Smart Money Score for RPRX is 66 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
115 institutions opened new positions in RPRX during Q1 2026, while 72 fully exited. 385 added to existing positions and 73 trimmed.
RPRX institutional ownership rose by 12.50 percentage points quarter-over-quarter, with a net change of +43 holders.
The top 10 institutions account for 55.9% of all reported 13F value in RPRX, and the top 25 account for 72.2%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Royalty Pharma plc (RPRX) Institutional Ownership